/ /

Michelle Dalton
Intraoperative aberrometry providing ‘tighter’ outcomes
“As we all know, errors in those initial measurements can have a negative effect on refractive outcomes,” Robert J. Cionni, MD, said. “Our goal is to get it right the first time.”
UGH rare, but potentially devastating complication
Patients who have uveitis-glaucoma-hyphema (UGH) syndrome caused by the complications after implantation of an anterior chamber IOL fared worse with final visual outcomes than patients who also develop UGH but have other lenses implanted.
What literature review says about modern LASIK
A systemic review of the peer-review literature has shown modern LASIK surgery is more effective and produces better outcomes than has been reported historically, said Kerry Solomon, MD.
Get involved, urges incoming ASCRS president
This year’s American Society of Cataract and Refractive Surgery (ASCRS) opening session zeroed in on one message: Members need to continue to be involved to ensure the society can meet members’ needs—from education to influence in the federal government.
New glaucoma drug delivery devices home in on compliance
Patient compliance (and non-compliance, as the case may be) is nothing new when discussing glaucoma. Nor are the multiple devices and systems previously developed or under investigation with the hope of improving compliance, said Richard Lewis, MD, speaking here at Glaucoma Day at ASCRS 2016.
Cosmetic iris implants dubbed ‘public safety hazard’
Cosmetic iris implants were first developed in Panama, where more than 700 people received bilateral implants between 2006 and 2010, said Tal Raviv, MD, speaking here at Cornea Day at ASCRS 2016.
When is crosslinking appropriate?
Though the main benefit of collagen corneal crosslinking is to stop progression of keratoconus, it is not the sole benefit, said Theo Seiler, MD, PhD (Greece) here during Cornea Day at ASCRS 2016.
Was 2015 the year of inlays, FLACS, or something else?
While 2015 may not have been the year for ground-breaking introductions or trials in the field of refractive surgery, plenty of improvements have kept the procedure an evolving process, Ophthalmology Times editorial advisory board members said.
What’s new in corneal surgery in 2015
Corneal surgeons thought 2015 would be the year that collagen crosslinking (CXL) for the treatment of keratoconus would be approved in the United States, but the FDA’s decision on Avedro’s KXL system is not expected until April 2016.
Easier ways to identify compromised corneas
Over the past few years, various diagnostics have been introduced to help clinicians identify inflammatory conditions on the ocular surface more readily and, therefore, provide treatment to patients earlier in their disease states.


View Results